Join
Live feed
·
PRReleasevia Quantisnow
Trevena Inc. logo

Trevena Announces Preliminary TRV045 Data from Two Proof-of-Concept Studies Evaluating S1PR Mechanism of Action and CNS Target Engagement

ByQuantisnow·Wall Street's wire, on your screen.
TRVN· Trevena Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track TRVN (Trevena Inc.) and more on Quantisnow.